EcoDrugPlus


Synonyms	Ashtons Callanish Cod liver oil Ennogen First choice Good health Healthchecks House of health Morhulin Natrahealth Neutraceuticals Noratex Oleum morrhuae Peel Primacy Quest Thovaline Total body care Totavit Valuvit Willowcare preps
Status
Molecule Category	UNKNOWN
UNII	BBL281NWFG

Synonyms

Ashtons

Callanish

Cod liver oil

Ennogen

First choice

Good health

Healthchecks

House of health

Morhulin

Natrahealth

Neutraceuticals

Noratex

Oleum morrhuae

Peel

Primacy

Quest

Thovaline

Total body care

Totavit

Valuvit

Willowcare preps

Status

Molecule Category

UNKNOWN

UNII

BBL281NWFG


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Mechanism of Action	Action	Reference
Supplement	None	DailyMed

Mechanism of Action

Action

Reference

Supplement

None

DailyMed

Resources	Reference
ChEMBL	CHEMBL2108234
FDA SRS	BBL281NWFG

Resources

Reference

ChEMBL

CHEMBL2108234

FDA SRS

BBL281NWFG


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

COD LIVER OIL

Bioactivity

Cross References